Everest Clinical Research.
Follow Everest Clinical ResearchEverest Clinical Research is a Toronto-based, data-first, full-service contract research organization serving pharmaceutical, biotechnology and medical device companies across Phase I to IV trials. Founded in 2004, it has been backed by Arlington Capital Partners since a 2020 majority investment. In September 2026 it acquired Firma Clinical Research's Biometrics and Data Services business unit.[1][2]
Deals on Carrywatch
Every deal that names Everest Clinical Research, and its role in each.
Everest Clinical Research (Arlington-backed) / Firma's Biometrics and Data Services unit
Arlington-backed Everest Clinical Research acquired Firma Clinical Research's Biometrics and Data Services unit, Everest announced Sept. 17, 2026.
Backed by Arlington Capital Partners.
See deal detailsDeal Web
Everest Clinical Research and 3 firms it shares a posted deal with, and the path to any other firm.
People
People on Carrywatch linked to Everest Clinical Research. Current and Former come from sourced profiles; a role that only appears in a post is shown as stated, with its status not confirmed.
News
Loading headlines.
Sources
As of 26 Sep 2026.
- 01Everest Clinical Research Expands Global Biometrics Capabilities with Acquisition of Firma Clinical Research's Data Services Business Unit
Everest Clinical Research (press release) · 17 Sep 2026 · Researched 26 Sep 2026
- 02Arlington Capital, in Partnership with Management, Announces Investment in Everest Clinical Research Corporation
Arlington Capital Partners (press release) · 7 Dec 2020 · Researched 26 Sep 2026
Deal posts naming Everest Clinical Research:
- P01